Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
Clinical trial NCT03070392 · COMPLETED
Trial details
- NCT number
- NCT03070392
- Sponsor
- Immunocore Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-16
- Primary completion
- 2020-10-13
- Enrollment
- 378
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.